Mark Cuban online pharmacy to offer AbbVie Humira biosimilar

Mark Cuban Cost Plus Drug Company will offer a biosimilar version of AbbVie's (NYSE:ABBV) Humira (adalimumab) manufactured by Coherus BioSciences (NASDAQ:CHRS) known as Yusimry starting in July.